Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan

Yuji Higuchi, Masaki Fujiwara, Naoki Nakaya, Maiko Fujimori, Chinatsu Hayashibara, Ryuhei So, Ikuta Shinkawa, Kojiro Sato, Yuji Yada, Masafumi Kodama, Hiroshi Takenaka, Yoshiki Kishi, Kyoko Kakeda, Yosuke Uchitomi, Norihito Yamada, Masatoshi Inagaki

Research output: Contribution to journalArticle

Abstract

BACKGROUND: We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. METHODS: Participants were outpatients with schizophrenia aged 20-69 years who had been visiting the hospital for ≥1 year as of April 1, 2016, and had visited the hospital more than once in the previous 6 months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (n = 680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1 year, and quitting rate from a naturalistic 1-year smoking-cessation follow up. RESULTS: The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0%) were followed for 1 year, 79 (70.0%) were interested in smoking cessation, and only 7 had received smoking cessation treatments at baseline. Among the tracked 104 participants, only 6 (5.8%) stopped smoking after 1 year. Among the 25 participants who had intentions to quit smoking within 6 months at baseline, 6 (24.0%) maintained their intention to quit smoking for 1 year, and 16 (64.0%) did not maintain their intention to quit smoking. CONCLUSIONS: Our findings showed that many smokers with schizophrenia were interested in quitting smoking, but few patients received treatment and actually quit smoking. Timely intervention, including the option to receive smoking cessation treatment, is necessary for those patients with schizophrenia who smoke. TRIAL REGISTRATION: UMIN Clinical Trials Registry (UMIN000023874, registered on August 31, 2016).

Original languageEnglish
Number of pages1
JournalBMC psychiatry
Volume19
Issue number1
DOIs
Publication statusPublished - Nov 21 2019

Fingerprint

Smoking Cessation
Schizophrenia
Japan
Smoking
Withholding Treatment
Smoke
Registries
Outpatients
Clinical Trials

Keywords

  • Cigarettes
  • Mental health
  • Schizophrenia
  • Smoking
  • Tobacco products

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Change in smoking cessation stage over 1 year in patients with schizophrenia : a follow up study in Japan. / Higuchi, Yuji; Fujiwara, Masaki; Nakaya, Naoki; Fujimori, Maiko; Hayashibara, Chinatsu; So, Ryuhei; Shinkawa, Ikuta; Sato, Kojiro; Yada, Yuji; Kodama, Masafumi; Takenaka, Hiroshi; Kishi, Yoshiki; Kakeda, Kyoko; Uchitomi, Yosuke; Yamada, Norihito; Inagaki, Masatoshi.

In: BMC psychiatry, Vol. 19, No. 1, 21.11.2019.

Research output: Contribution to journalArticle

Higuchi, Y, Fujiwara, M, Nakaya, N, Fujimori, M, Hayashibara, C, So, R, Shinkawa, I, Sato, K, Yada, Y, Kodama, M, Takenaka, H, Kishi, Y, Kakeda, K, Uchitomi, Y, Yamada, N & Inagaki, M 2019, 'Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan', BMC psychiatry, vol. 19, no. 1. https://doi.org/10.1186/s12888-019-2351-9
Higuchi, Yuji ; Fujiwara, Masaki ; Nakaya, Naoki ; Fujimori, Maiko ; Hayashibara, Chinatsu ; So, Ryuhei ; Shinkawa, Ikuta ; Sato, Kojiro ; Yada, Yuji ; Kodama, Masafumi ; Takenaka, Hiroshi ; Kishi, Yoshiki ; Kakeda, Kyoko ; Uchitomi, Yosuke ; Yamada, Norihito ; Inagaki, Masatoshi. / Change in smoking cessation stage over 1 year in patients with schizophrenia : a follow up study in Japan. In: BMC psychiatry. 2019 ; Vol. 19, No. 1.
@article{bf5ed1475e13489f80a5363ed5927e43,
title = "Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan",
abstract = "BACKGROUND: We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. METHODS: Participants were outpatients with schizophrenia aged 20-69 years who had been visiting the hospital for ≥1 year as of April 1, 2016, and had visited the hospital more than once in the previous 6 months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (n = 680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1 year, and quitting rate from a naturalistic 1-year smoking-cessation follow up. RESULTS: The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0{\%}) were followed for 1 year, 79 (70.0{\%}) were interested in smoking cessation, and only 7 had received smoking cessation treatments at baseline. Among the tracked 104 participants, only 6 (5.8{\%}) stopped smoking after 1 year. Among the 25 participants who had intentions to quit smoking within 6 months at baseline, 6 (24.0{\%}) maintained their intention to quit smoking for 1 year, and 16 (64.0{\%}) did not maintain their intention to quit smoking. CONCLUSIONS: Our findings showed that many smokers with schizophrenia were interested in quitting smoking, but few patients received treatment and actually quit smoking. Timely intervention, including the option to receive smoking cessation treatment, is necessary for those patients with schizophrenia who smoke. TRIAL REGISTRATION: UMIN Clinical Trials Registry (UMIN000023874, registered on August 31, 2016).",
keywords = "Cigarettes, Mental health, Schizophrenia, Smoking, Tobacco products",
author = "Yuji Higuchi and Masaki Fujiwara and Naoki Nakaya and Maiko Fujimori and Chinatsu Hayashibara and Ryuhei So and Ikuta Shinkawa and Kojiro Sato and Yuji Yada and Masafumi Kodama and Hiroshi Takenaka and Yoshiki Kishi and Kyoko Kakeda and Yosuke Uchitomi and Norihito Yamada and Masatoshi Inagaki",
year = "2019",
month = "11",
day = "21",
doi = "10.1186/s12888-019-2351-9",
language = "English",
volume = "19",
journal = "BMC Psychiatry",
issn = "1471-244X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Change in smoking cessation stage over 1 year in patients with schizophrenia

T2 - a follow up study in Japan

AU - Higuchi, Yuji

AU - Fujiwara, Masaki

AU - Nakaya, Naoki

AU - Fujimori, Maiko

AU - Hayashibara, Chinatsu

AU - So, Ryuhei

AU - Shinkawa, Ikuta

AU - Sato, Kojiro

AU - Yada, Yuji

AU - Kodama, Masafumi

AU - Takenaka, Hiroshi

AU - Kishi, Yoshiki

AU - Kakeda, Kyoko

AU - Uchitomi, Yosuke

AU - Yamada, Norihito

AU - Inagaki, Masatoshi

PY - 2019/11/21

Y1 - 2019/11/21

N2 - BACKGROUND: We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. METHODS: Participants were outpatients with schizophrenia aged 20-69 years who had been visiting the hospital for ≥1 year as of April 1, 2016, and had visited the hospital more than once in the previous 6 months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (n = 680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1 year, and quitting rate from a naturalistic 1-year smoking-cessation follow up. RESULTS: The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0%) were followed for 1 year, 79 (70.0%) were interested in smoking cessation, and only 7 had received smoking cessation treatments at baseline. Among the tracked 104 participants, only 6 (5.8%) stopped smoking after 1 year. Among the 25 participants who had intentions to quit smoking within 6 months at baseline, 6 (24.0%) maintained their intention to quit smoking for 1 year, and 16 (64.0%) did not maintain their intention to quit smoking. CONCLUSIONS: Our findings showed that many smokers with schizophrenia were interested in quitting smoking, but few patients received treatment and actually quit smoking. Timely intervention, including the option to receive smoking cessation treatment, is necessary for those patients with schizophrenia who smoke. TRIAL REGISTRATION: UMIN Clinical Trials Registry (UMIN000023874, registered on August 31, 2016).

AB - BACKGROUND: We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. METHODS: Participants were outpatients with schizophrenia aged 20-69 years who had been visiting the hospital for ≥1 year as of April 1, 2016, and had visited the hospital more than once in the previous 6 months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (n = 680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1 year, and quitting rate from a naturalistic 1-year smoking-cessation follow up. RESULTS: The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0%) were followed for 1 year, 79 (70.0%) were interested in smoking cessation, and only 7 had received smoking cessation treatments at baseline. Among the tracked 104 participants, only 6 (5.8%) stopped smoking after 1 year. Among the 25 participants who had intentions to quit smoking within 6 months at baseline, 6 (24.0%) maintained their intention to quit smoking for 1 year, and 16 (64.0%) did not maintain their intention to quit smoking. CONCLUSIONS: Our findings showed that many smokers with schizophrenia were interested in quitting smoking, but few patients received treatment and actually quit smoking. Timely intervention, including the option to receive smoking cessation treatment, is necessary for those patients with schizophrenia who smoke. TRIAL REGISTRATION: UMIN Clinical Trials Registry (UMIN000023874, registered on August 31, 2016).

KW - Cigarettes

KW - Mental health

KW - Schizophrenia

KW - Smoking

KW - Tobacco products

UR - http://www.scopus.com/inward/record.url?scp=85075530246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075530246&partnerID=8YFLogxK

U2 - 10.1186/s12888-019-2351-9

DO - 10.1186/s12888-019-2351-9

M3 - Article

C2 - 31752799

AN - SCOPUS:85075530246

VL - 19

JO - BMC Psychiatry

JF - BMC Psychiatry

SN - 1471-244X

IS - 1

ER -